Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae Hee Cheon

Showing results (1-10 of 433) with videos related to

Pageof 44
Sort By:
Journal of Gastroenterology and Hepatology|November 30, 2012
Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectivesJae Hee Cheon
Journal of Gastroenterology and Hepatology|October 11, 2016
Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel diseaseJae Hee Cheon
Intestinal Research|February 8, 2023
Past, present, and future of Intestinal ResearchJae Hee Cheon
Journal of Rheumatic Diseases|July 21, 2023
Advances in Management of Intestinal Behçet's Disease: A Perspective From GastroenterologistsJae Hee Cheon
Journal of Pathology and Translational Medicine|May 29, 2015
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic EvaluationsJae Hee Cheon
The Korean Journal of Internal Medicine|July 26, 2022
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-αJihye Park, Jae Hee Cheon
Intestinal Research|July 4, 2017
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?Jihye Park, Jae Hee Cheon
Current Gastroenterology Reports|March 21, 2020
Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic AgentsYehyun Park, Jae Hee Cheon
Gut and Liver|September 15, 2021
Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?Jihye Park, Jae Hee Cheon
Gut and Liver|May 24, 2018
Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's DiseaseJihye Park, Jae Hee Cheon
Pageof 44

Showing results (1-10 of 433) with videos related to

Sort By:
Pageof 44
Journal of Gastroenterology and Hepatology|November 30, 2012
Genetics of inflammatory bowel diseases: a comparison between Western and Eastern perspectivesJae Hee Cheon
Journal of Gastroenterology and Hepatology|October 11, 2016
Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel diseaseJae Hee Cheon
Intestinal Research|February 8, 2023
Past, present, and future of Intestinal ResearchJae Hee Cheon
Journal of Rheumatic Diseases|July 21, 2023
Advances in Management of Intestinal Behçet's Disease: A Perspective From GastroenterologistsJae Hee Cheon
Journal of Pathology and Translational Medicine|May 29, 2015
Advances in the Endoscopic Assessment of Inflammatory Bowel Diseases: Cooperation between Endoscopic and Pathologic EvaluationsJae Hee Cheon
The Korean Journal of Internal Medicine|July 26, 2022
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-αJihye Park, Jae Hee Cheon
Intestinal Research|July 4, 2017
Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?Jihye Park, Jae Hee Cheon
Current Gastroenterology Reports|March 21, 2020
Update on the Treatment of Behcet's Disease of the Small Bowel with Biologic AgentsYehyun Park, Jae Hee Cheon
Gut and Liver|September 15, 2021
Can Anti-Tumor Necrosis Factor Agents Be Discontinued in Patients with Inflammatory Bowel Disease?Jihye Park, Jae Hee Cheon
Gut and Liver|May 24, 2018
Anti-Tumor Necrosis Factor Therapy in Intestinal Behçet's DiseaseJihye Park, Jae Hee Cheon
Pageof 44